Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Pironetin Preferentially Inhibits Microtubule Minus-End Growth and Enables Polarity Marking.

Created on 26 Oct 2026

Authors

Olga V Vasilieva, Ilya A Lifshits, Alena V Korshunova, Nadezhda A Orlova, Ivan I Vorobiev, Nikita B Gudimchuk

Published in

Biochemistry. Biokhimiia. Volume 91. Issue 10. Pages 2031-2043.

Abstract

Microtubules are dynamic cytoskeletal polymers and major targets of anticancer drugs that modulate their assembly dynamics. Here, we characterized the effects of two tubulin-targeting ligands, pironetin and maytansine, on microtubule dynamics in vitro and developed a method for generating polarity-marked microtubules based on asymmetric growth inhibition. Using total internal reflection fluorescence (TIRF) microscopy, kymograph analysis, and kinesin-1 gliding assays, we found that maytansine efficiently suppressed polymerization at both microtubule ends, whereas pironetin preferentially inhibited minus-end growth, while exerting only a minor effect on plus-end polymerization. This pronounced end-selectivity enabled the generation of two-color segmented microtubules with reliably identifiable polarity. After optimization, the pironetin-based protocol achieved performance comparable to that of the established N-ethylmaleimide (NEM)-based method while preserving the biochemical integrity of the microtubule lattice owing to the well-defined binding site of pironetin on α-tubulin. Our results identify pironetin as a promising tool for generating polarity-marked microtubules for in vitro studies of microtubule dynamics and interactions with end-specific microtubule-associated proteins.

PMID:
42927760
Bibliographic data and abstract were imported from PubMed on 26 Oct 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 11
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement